Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company has several commercialized drugs across anti-infective, cardiovascular, CNS, and other major disease areas, with a significant number of products in the pipeline and approval track (notably piperacillin sodium/sulbactam sodium, secobarbital sodium, cefoperazone sodium). Recognized as a leader in both generic and branded drug development in China, with a strong export business and growing international presence through acquisitions such as GNC.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Yesharp Pharmaceutical.